Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02785250 |
| Title | Study of DPX-Survivac Vaccine Therapy and Epacadostat in Patients With Recurrent Ovarian Cancer |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | ImmunoVaccine Technologies, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94304 | United States | Details | |
| Georgia Cancer Center at Augusta University | Augusta | Georgia | 30912 | United States | Details | |
| Lenox Hill Hospital | New York | New York | 10028 | United States | Details | |
| Oregon Health & Sciences University, Knight Cancer Institute | Portland | Oregon | 97239 | United States | Details | |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| Mary Crowley Cancer Research Center | Dallas | Texas | 75230 | United States | Details | |
| Tom Baker Cancer Centre | Calgary | Alberta | Canada | Details | ||
| Princess Margaret Hospital | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Centre Hospitalier de l'Université de Montréal (CHUM) | Montréal | Quebec | H2X 3E4 | Canada | Details |